Simris Group Feed

2025-07-12 06:38:00 Partner Company Decides Not to Proceed with Simris Group ADC Proposed Collaboration Following Strategic Review

2025-06-05 09:15:00 Simris Biologics Signs Agreement with Nuvisan for In-Vivo Evaluation of Novel Microcystin Payloads 0,13 SEK | +18,18%

2025-06-02 08:55:00 Simris Group AB Signs Non-Binding Concept Sheet for Potential Antibody-Drug Conjugate Collaboration 0,09 SEK | +16,79%

2025-05-28 17:10:00 Bulletin from Simris Group AB’s annual general meeting 0,08 SEK | +1,29%

2025-05-14 08:00:00 SIMRIS GROUP INTERIM REPORT JANUARY-MARCH 2025 0,07 SEK | -9,76%

2025-04-25 15:00:00 Notice of the Annual General Meeting of Simris Group AB (publ) 0,10 SEK | 0,00%

2025-04-16 18:05:00 Simris Group enters into bridge loan agreement, extends loan agreements with investors and intends to propose that the annual general meeting resolves to extend loan agreements with management 0,09 SEK | +0,21%

2025-04-16 15:00:00 SIMRIS GROUP PUBLISHES ITS ANNUAL REPORT FOR 2024 0,09 SEK | -0,21%

2025-03-25 08:00:00 Refined Microcystin Payloads Show Promising In-Vitro Efficacy, Paving Way for Next-Generation Variants 0,13 SEK | +13,51%

2025-02-26 08:00:00 SIMRIS GROUP YEAR-END REPORT JANUARY-DECEMBER 2024 0,09 SEK | +2,26%

2025-01-20 14:18:00 Bulletin from Simris Group AB’s Extraordinary General Meeting 0,09 SEK | +3,33%

2024-12-23 11:07:00 Notice of Extraordinary General Meeting of Simris Group AB (publ) 0,09 SEK | +71,31%

2024-12-23 09:44:00 Simris resolves on a share issue, repayment of convertible debentures, prolongation of loan agreements, entering into and to call for a general meeting to resolve to enter into new loan agreements 0,09 SEK | +71,31%

2024-11-13 08:00:00 SIMRIS GROUP INTERIM REPORT JANUARY-SEPTEMBER 2024 0,12 SEK | +32,61%

2024-10-23 18:04:00 Uncertainty regarding when the next payment from the agreed loan facility can occur 0,09 SEK | -10,75%

2024-10-18 18:22:00 Simris Group chairman and major owner Steven Schapera has passed away after complications after surgery

2024-09-09 08:00:00 Simris Biologics awarded funding for a research collaboration with Berlin's University of Applied Science to explore the ability of natural compounds from Cyanobacteria to delay aging 0,13 SEK | +10,64%

2024-08-14 08:00:00 SIMRIS GROUP INTERIM REPORT JANUARY-JUNE 2024 0,14 SEK | +0,37%

2024-07-09 15:45:00 Simris Biologics enters into a collaboration agreement with New Zealand Universities to develop peptide drug conjugates (PDC) 0,16 SEK | +9,12%

2024-06-28 11:15:00 Bulletin from Simris Group AB (publ)’s Annual General Meeting 0,16 SEK | -0,31%

2024-05-27 18:35:00 Notice of the Annual General Meeting of Simris Group AB (publ) 0,17 SEK | -16,54%

2024-05-15 08:00:00 SIMRIS GROUP INTERIM REPORT JANUARY-MARCH 2024 0,16 SEK | +32,92%

2024-04-29 14:00:00 SIMRIS GROUP AB ANNOUNCED TODAY THAT THE BOARD HAS DECIDED TO MOVE THE COMPANY'S ANNUAL GENERAL MEETING FROM MAY 29, 2024 TO JUNE 28, 2024 0,13 SEK | 0,00%

2024-04-23 14:10:00 Simris Group AB (publ) announces the outcome of the directed offer of convertible debentures 0,13 SEK | -5,62%

2024-04-17 14:45:00 SIMRIS GROUP PUBLISHES ITS ANNUAL REPORT FOR 2023 0,13 SEK | +0,38%

2024-04-15 20:30:00 SIMRIS GROUP CONFIRMS A TERM EXTENSION TO FLEXIBLE FUNDING FACILITY 0,13 SEK | -1,12%

2024-04-05 11:15:00 Bulletin from Simris Group’s Extraordinary General Meeting 0,14 SEK | -11,18%

2024-03-19 19:33:00 Notice of Extraordinary General Meeting of Simris Group AB (publ) 0,13 SEK | -9,03%

2024-03-15 21:34:00 The board of Simris Group AB (publ) resolves to change the terms of the directed issue of convertible debentures by increasing from EUR 1.0m to EUR €1.15m subject to the approval of the general meeting. 0,15 SEK | +5,15%

2024-03-14 18:35:00 The board of Simris Group AB (publ) resolves on a directed issue of convertible debentures up to EUR 1,000,000 subject to the approval of the General Meeting. 0,15 SEK | +1,75%

2024-03-12 21:10:00 Julian Read steps down as CEO of Simris Group. The Board of Simris appoints Dr Alexis Roberts-McIntosh as his successor with immediate effect. 0,13 SEK | +10,43%

2024-03-06 09:02:00 Simris Group AB confirms that it will temporarily pause production at its facility in Hammenhög, Sweden 0,16 SEK | -23,57%

2024-02-28 08:00:00 SIMRIS GROUP YEAR-END REPORT JANUARY-DECEMBER 2023 0,22 SEK | -2,65%

2024-01-10 08:00:00 Simris signs Head of Terms for an offtake agreement valued at minimum €2m / SEK 22m 0,24 SEK | +7,46%

2023-12-20 10:45:00 Bulletin from Simris Group’s Extraordinary General Meeting 0,25 SEK | +4,13%

2023-12-20 09:45:00 Simris Biologics signs Material Transfer Agreement with pre-clinical biotech company to develop Linker-Payloads 0,25 SEK | +4,13%

2023-12-01 16:01:00 Notice of Extraordinary General Meeting of Simris Group AB (publ) 0,25 SEK | -0,40%

2023-12-01 16:00:00 The board of Simris Group AB (publ) proposes a directed share issue of approximately MSEK 1.55 0,25 SEK | -0,40%

2023-11-15 14:15:00 Simris Biologics awarded €163,000 for the genetic engineering of cyanobacterial strains during an 18-month project beginning January 2024 0,26 SEK | -0,38%

2023-11-08 08:00:00 Simris Group: Interim Report January - September 2023 0,28 SEK | +10,94%

2023-11-07 15:30:00 Simris appoints a distribution partner for Omega-3 products in North America delivering revenue of approx., €60k, and annual cost savings of €200k 0,26 SEK | -0,39%

2023-10-29 19:55:00 Simris Group AB completes a directed share issue of approximately 3 MSEK to strategic investors 0,28 SEK | +2,58%

2023-09-11 14:40:00 Last day of trading with BTA in Simris Group 0,25 SEK | 0,00%

2023-08-18 19:32:00 Simris Group AB (Publ) announces the final outcome of the fully secured Rights Issue 0,29 SEK | +7,92%

2023-08-16 18:15:00 Preliminary subscription rate of Rights Issue in Simris Group AB (Publ) amounts to approximately 57 percent 0,27 SEK | -8,16%

2023-08-08 14:15:00 Simris Group CEO, Julian Read, answers questions from Finwire regarding company strategy and its ongoing Rights Issue 0,28 SEK | +5,58%

2023-08-08 14:15:00 Simris Group CEO, Julian Read, svarar på frågor från Finwire angående företagets strategi och den pågående företrädesemissionen 0,28 SEK | +5,58%

2023-08-04 14:55:00 SIMRIS GROUP SIGNS LETTER OF INTENT TO SECURE INDUSTRIAL SCALE PRODUCTION CAPACITY THROUGH COMMERCIAL PARTNERSHIP 0,26 SEK | -7,53%

↑	Select newer press release
↓	Select older press release
←	Navigate backwards
→	Navigate forward
Enter	Navigate to line in focus
Tab	Focus next link
A or 1	Open First attachment
S or 2	Open Second attachment
D or 3	Open Third attachment
F or 4	Open Fourth attachment
I	Show company information
PgUp	Select newest press release
PgDown	Select oldest press release
L	Focus on filer bar
N	Increase preview window size
M	Decrease preview window size
Esc	Escape from mode

Simris Group

Språk

Typ

År

Språk

Typ

Ett mail har skickats till den givna adressen. För att logga in, klicka på "Login" i mailet för att verifiera ditt konto

Företag

Pressmeddelanden